器官采购的未来 器官采购的未来
1From the National Organization for Organ and Tissue Donation and Transplantation (NOD-Lb), Baabda, Lebanon.
概括
器官捐献的自给自足可以在2023年之前实现. 策略包括通过SGLT2抑制剂延缓功能衰竭,并通过生物人工脏和异种移植增加器官供应.
科学领域:
- 科和移植科学 科和移植科学
- 再生医学是一种再生医学.
- 免疫学 免疫学 免疫学
背景情况:
- 器官采购组织努力实现自给自足,以满足患者的需求.
- 最终性功能衰竭影响了大量需要置换治疗的患者群体.
- 目前的器官供应不足以满足移植的需求.
研究的目的:
- 概述到2023年实现器官捐献自给自足的战略方法.
- 确定干预的关键领域,以平衡器官供需.
- 预测新兴医疗技术对移植结果的影响.
主要方法:
- 对衰竭进展和管理当前趋势的审查.
- 分析SGLT2抑制剂在延迟末期病中的潜力.
- 评估生物人工脏开发和异种移植研究的进展.
主要成果:
- SGLT2 抑制剂在延缓功能衰竭的进展方面表现出有效性,从而减少对的需求.
- 生物人工技术和异种移植为增加器官供应提供了可行的途径.
- 减少需求和增加供应的联合战略可以促进器官自给自足.
结论:
- 到2023年实现对脏移植的器官自给是现实的目标.
- 像SGLT2抑制剂这样的药理干预措施对于管理需求至关重要.
- 在再生医学和跨物种移植方面的创新对于增加器官供应至关重要.
相关概念视频
01:24Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
01:22Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330